A detailed history of Sg Americas Securities, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 25,086 shares of ORGO stock, worth $89,055. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,086
Holding current value
$89,055
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$2.42 - $3.24 $60,708 - $81,278
25,086 New
25,086 $72,000
Q1 2024

May 06, 2024

SELL
$2.61 - $4.49 $37,085 - $63,798
-14,209 Reduced 39.72%
21,565 $61,000
Q4 2023

Jan 12, 2024

BUY
$1.97 - $4.21 $13,252 - $28,320
6,727 Added 23.16%
35,774 $146,000
Q3 2023

Oct 13, 2023

BUY
$2.34 - $4.43 $67,969 - $128,678
29,047 New
29,047 $92,000
Q1 2023

Apr 28, 2023

BUY
$1.89 - $2.93 $56,295 - $87,272
29,786 New
29,786 $63,000
Q3 2022

Oct 31, 2022

SELL
$3.14 - $6.43 $132,580 - $271,493
-42,223 Reduced 76.63%
12,875 $42,000
Q2 2022

Jul 29, 2022

BUY
$4.74 - $8.15 $125,932 - $216,529
26,568 Added 93.12%
55,098 $269,000
Q1 2022

Apr 29, 2022

SELL
$6.47 - $9.57 $253,022 - $374,253
-39,107 Reduced 57.82%
28,530 $217,000
Q4 2021

Feb 07, 2022

BUY
$9.02 - $13.5 $181,365 - $271,444
20,107 Added 42.3%
67,637 $625,000
Q3 2021

Nov 01, 2021

BUY
$13.71 - $17.18 $651,636 - $816,565
47,530 New
47,530 $677,000
Q2 2021

Aug 12, 2021

SELL
$14.92 - $23.23 $1.89 Million - $2.94 Million
-126,435 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$7.33 - $21.06 $926,768 - $2.66 Million
126,435 New
126,435 $2.3 Million
Q3 2020

Nov 09, 2020

SELL
$3.29 - $4.58 $35,864 - $49,926
-10,901 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$2.86 - $4.61 $31,176 - $50,253
10,901 New
10,901 $42,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $465M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.